Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,601,892 | 1,485,807 | 1,377,058 | 1,293,338 | 1,218,689 |
| Cost of Goods | 711,622 | 669,691 | 620,940 | 594,190 | 572,183 |
| Gross Profit | 890,270 | 816,116 | 756,118 | 699,148 | 646,506 |
| Operating Expenses | 590,980 | 556,552 | 490,296 | 436,775 | 410,464 |
| Operating Income | 299,912 | 260,255 | 266,762 | 262,563 | 236,225 |
| Interest Expense | 29,239 | 15,429 | 5,386 | 3,848 | 3,547 |
| Other Income | 2,468 | 1,729 | 1,885 | 1,902 | 1,744 |
| Pre-tax Income | 273,141 | 246,555 | 263,261 | 260,617 | 234,422 |
| Income Tax | 81,006 | 64,604 | 75,467 | 82,330 | 72,668 |
| Net Income Continuous | 192,135 | 181,951 | 187,794 | 178,287 | 161,754 |
| Minority Interests | 57 | 45 | -6 | 20 | -32 |
| Net Income | $192,078 | $181,906 | $187,800 | $178,267 | $161,786 |
| EPS Basic Total Ops | 2.07 | 1.82 | 1.77 | 1.62 | 1.43 |
| EPS Basic Continuous Ops | 2.07 | 1.82 | 1.77 | 1.62 | 1.42 |
| EPS Diluted Total Ops | 2.05 | 1.79 | 1.74 | 1.59 | 1.39 |
| EPS Diluted Continuous Ops | 2.05 | 1.79 | 1.74 | 1.59 | 1.39 |
| EBITDA(a) | $370,300 | $319,143 | $321,358 | $314,971 | $284,427 |